SEATTLE--(BUSINESS WIRE)--Frazier Healthcare, a leading provider of growth capital to healthcare companies, announces that Brett Moraski has joined Frazier's Growth Buyout team as an Operating Partner. He will assist the Growth Buyout team with identifying investment opportunities in payor services and IT-enabled ancillary services to the payor industry.
Previously, Brett was a Senior Operating Advisor at LLR Partners and Corporate Vice President of Transformation at WellPoint, a Fortune 50 health insurance company, where he headed the company’s HealthyCare Solutions business unit. Prior to his appointment, Brett led Corporate Strategy and Innovation at WellPoint and was responsible for managing both WellPoint’s enterprise strategic planning activities and leading WellPoint’s corporate innovation activities, including founding the company’s FutureVentures business unit which invests in key corporate innovation initiatives.
Prior to joining WellPoint, Brett was Senior Vice President of Corporate Strategy and Development at Highmark Blue Cross Blue Shield for seven years. In this role, he assumed responsibility for all strategy, innovation, corporate development, and market research and analysis activities for this $13 billion diversified health plan. He also sat on the board of directors and advisory committees of Eye Care Centers of America, United Concordia Dental, HM Insurance Group, NaviNet, Gateway Health Plan, Inter-County Health Plan, Lancet Capital Partners, Birchmere Ventures and Highmark Health Ventures.
“We’re thrilled to have attracted Brett to our team,” added Ben Magnano, General Partner. "Since our successful exit from Bravo Health, we have worked hard to identify executives and investment opportunities in the diversified payor services space. Brett brings a powerful combination of payor industry operating experience and a deep network of relationships that will assist in platform identification and ultimate investment.”
About Frazier Healthcare
Founded in 1991, Frazier Healthcare is a leading provider of venture and growth buyout capital to healthcare companies. With over $2 billion under management, Frazier Healthcare has invested in more than 150 companies across the entire development spectrum. From venture investments to leveraged recapitalizations, Frazier Healthcare has established itself among entrepreneurs and seasoned executives as a preferred partner to help create and grow successful healthcare companies. The Growth Buyout team at Frazier focuses on investments in healthcare services, pharmaceutical services, healthcare information technology, products, supplies, and specialty distribution.
For more information about Frazier Healthcare, visit the company's website at www.frazierhealthcare.com